Navigation Links
Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
Date:12/4/2007

Two Separate Clinical Studies Planned for Cancer and Inflammatory Disease

PRINCETON, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today the allowance of two separate investigational new drug applications (IND) filed with the U.S. Food & Drug Administration (FDA) for MDX-1342, one for the treatment of chronic lymphocytic leukemia (CLL) and the other for rheumatoid arthritis. MDX-1342 is a fully human antibody that targets CD19, a molecule specifically expressed on normal B-cells and malignant B-cells in diseases such as CLL, acute lymphoblastic leukemia, follicular non-Hodgkins lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma.

The IND for the treatment of CLL is for an open-label, multi-dose, dose-escalation Phase I clinical trial for cancer that is expected to enroll up to 52 patients with relapsed or refractory CLL. This trial is designed to establish and evaluate the safety, tolerability and maximum tolerated dose, as well as preliminary pharmacodynamics and efficacy of MDX-1342.

The IND for the treatment of rheumatoid arthritis is for a randomized, single-dose, dose-escalation, placebo-controlled Phase I clinical trial that is expected to enroll up to 90 patients with rheumatoid arthritis. This trial is designed to evaluate the safety and tolerability profile of MDX-1342 and to determine the dose range for B-cell depletion.

"We are pleased with the advancement of a new product candidate from Medarex's proprietary pipeline into clinical trials," said Howard H. Pien, President and CEO of Medarex. "We look forward to the continued development of MDX-1342, which could provide new treatment options for a number of serious conditions."

About
'/>"/>

SOURCE Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced the addition ... Business Report" report to their offering. The ... Canada , Japan , ... of World. Annual estimates and forecasts are provided for the ... provided for these markets. The global market is ...
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research ... announced the addition of the "Asia-Pacific Internal ... End-User - Analysis and Forecast To 2019" ... Internal Trauma Fixation Devices market is estimated to ... to 2019. Factors, such as technological advancement, rising ...
(Date:5/6/2015)... YORK , May 6, 2015   CEFALY ... electrical nerve stimulation device specifically authorized for use prior ... announce significant breakthroughs in migraine treatment at the EUROHEADPAIN ... in Valencia, Spain , from May ... at a meeting of EUROHEADPAIN, a major European research ...
Breaking Medicine Technology:Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... HONG KONG , July 22 /PRNewswire-Asia-FirstCall/ ... ("Golden,Meditech" or the "Group," HKEx: 801) is pleased to ... March 2010 . During the reporting period, total ... consolidate revenue from the,cord blood banking division into its ...
... , July 22 Nile Therapeutics, Inc. (Nasdaq: ... therapeutics for cardiovascular disease, today announced the appointment of Richard ... biotech and pharmaceutical industry experience, Mr. Brewer brings a wealth of ... , , ...
Cached Medicine Technology:Golden Meditech Announces Annual Results for FY 2009/10 2Golden Meditech Announces Annual Results for FY 2009/10 3Golden Meditech Announces Annual Results for FY 2009/10 4Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors 2Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors 3Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors 4
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, ... as having one the best Extra Virgin Olive Oils in ... region of Greece and known as Laconiko , received ... Medium Olive Oil, which is defined by the competition as ... 700 producer applicants from 25 different countries applying, Laconiko stood ...
(Date:5/6/2015)... May 06, 2015 Topical BioMedics, Inc., announces ... May 12th, from 12pm – 1pm, streamed live and then ... and open to the public by clicking on the following ... attendees are invited “real time” during the webinar, and questions ... , The topic for the May webinar is ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... Hollywood, Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe ... top providers of products and services that maintain ... Debbie Durkin, Los Angeles’ leading producer of TV ... Lunge is a premier red carpet event that ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, ... they will give away a deluxe human hair lace wig ... steps to enter on a third-party giveaway tool. The important ... can be the winner. , The hair is a crown, ... destination for such a jewel for the past 20 years. ...
(Date:5/6/2015)... Qualidigm , the national healthcare ... executive Ann Olson, RN, BSN, as a principal ... growing home healthcare services and develop strategic initiatives ... safety, and cost-effectiveness of healthcare through transformational change. ... of North Haven, Inc., a full-service home healthcare ...
Breaking Medicine News(10 mins):Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Choices Recovery Mishawaka Discusses the Many Forms of Addiction and Treatment with Terrah Bennett Smith 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3
... PLYMOUTH, Minn., Feb. 6 ev3 Inc. (Nasdaq: ... financial results and its financial guidance for 2009 on Tuesday, ... host a conference call and webcast the same day at ... management will review its fourth quarter and full-year operating results ...
... licensed practical nursing career resource center to learn about the many ... , ... Seattle, Washington (PRWEB) February 6, 2009 -- ... offers comprehensive career and education information for those who are ...
LOS ANGELES, Feb. 5 To clarify a comment I erred in making to a Los Angeles Times reporter, there was no payment of any sort by the NBC network to our client, Nadya Suleman, for her interview with ...
... Stater Bros. has raised over $1.9 million in the ... Bros. is once again partnering with the American Heart ... Heart Month, to help fight heart disease and stroke. ... "Have A Heart, Save A Heart" campaign to raise ...
... Feb. 5 ReBuilder Medical Technologies, Inc. (Pink Sheets: ... for diabetic peripheral neuropathy and Molluscum ... in sales for the month of January. (Logo: ... to be recession proof and this monthly sales turn ...
... New Rochelle, NY, February 5, 2009With the Obama ... health care reform, which at its core should ... prevention, chiropractic, and complementary and alternative medicine (CAM), ... (Volume 15, Number 1) of The Journal ...
Cached Medicine News:Health News:ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009 2Health News:Licensed Practical Nurse Career Resource Center Launches 2Health News:Licensed Practical Nurse Career Resource Center Launches 3Health News:Stater Bros. Campaigns to Fight Heart Disease and Stroke... At All Stater Bros. Supermarket Locations 2Health News:ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09 2Health News:Alternative and complementary medicine should have role in new era of health care reform 2
... The RX ACCUNET Embolic Protection System ... and easy filter control when performing carotid ... guide wire based filter system that utilizes ... can easily control the filter during catheter ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Provides surgeon's eye view of any procedure. View procedures live or edit tapes or digital files for later use. Extended field-of-vision maintains sharp focus from 8" to 36". Automatic Iris and Gain...
Medicine Products: